Oct 7 2025 12:00
Shiba Inu’s Waning Fortunes: Holder Count Dips for First Time in Two Years Amid Dwindling Volume
TG Therapeutics (TGTX) shows explosive EPS growth up to 1,300% and strong sales momentum. With a perfect 10 technical rating and a bullish chart setup, it's a high-growth stock to watch.







